Upstream Bio, Stock Market Value
| UPB Stock | 19.45 0.05 0.26% |
| Symbol | Upstream |
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Upstream Bio,. If investors know Upstream will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Upstream Bio, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Upstream Bio, is measured differently than its book value, which is the value of Upstream that is recorded on the company's balance sheet. Investors also form their own opinion of Upstream Bio,'s value that differs from its market value or its book value, called intrinsic value, which is Upstream Bio,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Upstream Bio,'s market value can be influenced by many factors that don't directly affect Upstream Bio,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Upstream Bio,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Upstream Bio, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Upstream Bio,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Upstream Bio, 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Upstream Bio,'s stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Upstream Bio,.
| 11/27/2024 |
| 12/27/2024 |
If you would invest 0.00 in Upstream Bio, on November 27, 2024 and sell it all today you would earn a total of 0.00 from holding Upstream Bio, or generate 0.0% return on investment in Upstream Bio, over 30 days. Upstream Bio, is related to or competes with Opus Genetics,, and Telix Pharmaceuticals. Upstream Bio, is entity of United States More
Upstream Bio, Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Upstream Bio,'s stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Upstream Bio, upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 6.41 | |||
| Information Ratio | 0.0618 | |||
| Maximum Drawdown | 50.21 | |||
| Value At Risk | (6.88) | |||
| Potential Upside | 10.61 |
Upstream Bio, Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Upstream Bio,'s investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Upstream Bio,'s standard deviation. In reality, there are many statistical measures that can use Upstream Bio, historical prices to predict the future Upstream Bio,'s volatility.| Risk Adjusted Performance | 0.064 | |||
| Jensen Alpha | 0.4473 | |||
| Total Risk Alpha | 0.0944 | |||
| Sortino Ratio | 0.0674 | |||
| Treynor Ratio | 0.7437 |
Upstream Bio, Backtested Returns
Upstream Bio, appears to be somewhat reliable, given 3 months investment horizon. Upstream Bio, owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0694, which indicates the firm had a 0.0694% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Upstream Bio,, which you can use to evaluate the volatility of the company. Please review Upstream Bio,'s Semi Deviation of 5.71, coefficient of variation of 1440.07, and Risk Adjusted Performance of 0.064 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Upstream Bio, holds a performance score of 5. The entity has a beta of 0.64, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Upstream Bio,'s returns are expected to increase less than the market. However, during the bear market, the loss of holding Upstream Bio, is expected to be smaller as well. Please check Upstream Bio,'s skewness, and the relationship between the potential upside and rate of daily change , to make a quick decision on whether Upstream Bio,'s existing price patterns will revert.
Auto-correlation | -0.78 |
Almost perfect reverse predictability
Upstream Bio, has almost perfect reverse predictability. Overlapping area represents the amount of predictability between Upstream Bio, time series from 27th of November 2024 to 12th of December 2024 and 12th of December 2024 to 27th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Upstream Bio, price movement. The serial correlation of -0.78 indicates that around 78.0% of current Upstream Bio, price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.78 | |
| Spearman Rank Test | -0.19 | |
| Residual Average | 0.0 | |
| Price Variance | 2.48 |
Upstream Bio, lagged returns against current returns
Autocorrelation, which is Upstream Bio, stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Upstream Bio,'s stock expected returns. We can calculate the autocorrelation of Upstream Bio, returns to help us make a trade decision. For example, suppose you find that Upstream Bio, has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Upstream Bio, regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Upstream Bio, stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Upstream Bio, stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Upstream Bio, stock over time.
Current vs Lagged Prices |
| Timeline |
Upstream Bio, Lagged Returns
When evaluating Upstream Bio,'s market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Upstream Bio, stock have on its future price. Upstream Bio, autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Upstream Bio, autocorrelation shows the relationship between Upstream Bio, stock current value and its past values and can show if there is a momentum factor associated with investing in Upstream Bio,.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Upstream Bio, offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Upstream Bio,'s financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Upstream Bio, Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Upstream Bio, Stock:Check out Upstream Bio, Correlation, Upstream Bio, Volatility and Upstream Bio, Alpha and Beta module to complement your research on Upstream Bio,. For information on how to trade Upstream Stock refer to our How to Trade Upstream Stock guide.You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Upstream Bio, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.